Guided Therapeutics, Inc.
GTHP
$0.2655
$0.035515.44%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.27% | -12.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.62% | -4.63% | |||
| Operating Income | 22.47% | 4.81% | |||
| Income Before Tax | 34.51% | 0.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.51% | 0.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.51% | 0.31% | |||
| EBIT | 22.47% | 4.81% | |||
| EBITDA | 22.56% | 4.83% | |||
| EPS Basic | 40.35% | 5.79% | |||
| Normalized Basic EPS | 44.12% | 6.85% | |||
| EPS Diluted | 48.19% | -59.50% | |||
| Normalized Diluted EPS | 44.12% | 6.85% | |||
| Average Basic Shares Outstanding | 10.92% | 7.94% | |||
| Average Diluted Shares Outstanding | 10.92% | 7.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||